Although coverage is below the Canadian Immunization Committee benchmark of 80% within two years of program implementation, the upward trend in coverage is encouraging.arahE.WilsonTaraHarrisPamSethiJillFediurekLianeSDOSVaccineS. Wilson, T. Harris, P. Sethi, et al., Coverage from Ontario, Canada'...
(2013). Coverage from Ontario, Canada’s school-based HPV vaccine program: The first three years. Vaccine, 13, 757–762. Article Google Scholar Naus, M., & Ogilvie, G. (2010). Human papillomavirus vaccine program in BC: A good start with room for improvement. BC Medical Journal, 52(...
However, at the time this study was performed, the HPV vaccine was not yet covered in Ontario for boys or gay men under the age of 26 years. Therefore, although it is unlikely that many of our participants would have received the HPV vaccine, it is not possible for us to completely ...
Effect of human papillomavirus (HPV) vaccination on clinical indicators of sexual behaviour among adolescent girls: the Ontario Grade 8 HPV Vaccine Cohort ... Suboptimal human papillomavirus (HPV) vaccine coverage in some jurisdictions is partly attributed to fears that vaccination may increase risky se...
Increasing acceptability and understanding among parents, as well as strengthening provider recommendations, will be necessary for expanding vaccine coverage and reducing disease burden [18]. Previous studies have found no evidence that HPV vaccination impacts sexual behavior, risk perception, or sexually ...
2015, British Columbia, Canada:there was a significant reduction in CIN2+ lesions in young women aged 15-17 years after the introduction of the HPV vaccine 2015, Ontario, Canada:vaccinated girls in grades 10-12 had about 44% fewer cases of cervical dysplasia and about 43% fewer cases of ...
Future II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions.N. Engl. J. Med.356, 1915–1927 (2007). ArticleGoogle Scholar Harper, D. M. et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papil...
Ten-year immune persistence and safety of the HPV-16/18 AS04-adjuvanted vaccine in females vaccinated at 15-55 years of age. Cancer Med. 2017;6(11... TF Schwarz,A Galaj,M Spaczynski,... - 《Cancer Medicine》 被引量: 0发表: 2017年 HPV vaccination coverage among women aged 18-20 ...
Vaccine (five-year coverage: 77.5%) was preferentially accepted by contraceptive-pill users (P = 0.001) and samples were mainly provided by sexually-active subjects (P < 0.001). The proportion (4%) of the vaccine-type HPV in this population was lower than in sub-study 2 outpatients (...
health policies and financing mechanisms should be developed and agreed upon by policymakers to ensure full or partial coverage of the self-collection for HPV testing services (i.e., Public-Private Partnerships (PPP) to cover costs associated with implementing and scaling-up). Further research shoul...